NICE backs Qarziba for children with high-risk neuroblastoma
admin 12th July 2018 Uncategorised 0NHS funding for EUSA’s Pharma’s Qarziba has been approved to treat children with high-risk neuroblastoma.
More: NICE backs Qarziba for children with high-risk neuroblastoma
Source: News